Innate Pharma S.A. Statistics
NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.8634-0.0765 (-8.14%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Innate Pharma S.A. by the numbers
Innate Pharma S.A. has a market capitalization of $96.4 million based on 111.70M shares outstanding. With trailing EPS of $-0.59, Innate Pharma S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 43.7% below its 50-day average and 48.6% below its 200-day average.
Average daily trading volume is 42.76K shares, or about $36,921 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IPHA valuation vs. peer median
| Metric | IPHA | Peer median | Difference |
|---|---|---|---|
| Market cap | $96.44M | $96.00M | +0% |
| Avg. volume | 42.76K | 1.05M | -96% |
Peer median across 8 companies: MOLN, VYGR, OTLK, LENZ, ZURA, CRDL, FATE, ARMP.
Valuation
- Market cap
- $96.44M
- EPS (TTM)
- $-0.59
- Shares outstanding
- 111.70M
Price and trading
- Previous close
- 0.9399
- Open
- 0.8841
- Day range
- 0.829 – 0.9084
- 52-week range
- 0.829 – 2.71
- 52-week change
- -52.56%
- Beta
- —
- Volume
- 18.03K
- Average volume
- 42.76K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 96.44M
- Forward Pe
- -1.86
- Eps
- -0.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.71
- Week52 Low
- 0.83
- Avg Volume
- 42,762.00
- Shares Outstanding
- 111.70M
- Ma50
- 1.53
- Ma200
- 1.68
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -68.14%
- Pct From52w Low
- 4.15%